Search

In part 2 of our roundtable discussion, thought leaders discuss what Trump could do for drug pricing and whether change is to be feared or embraced.

COVID-19 crisis has given researchers, financiers, and industrialists an extraordinary lesson. The mRNA vaccine represents, indeed, an extraordinary scientific and technological revolution. It is perhaps the

It’s December – time for The Medicine Maker to welcome you to 2023’s most innovative new technologies in drug development and manufacturing

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

What are the lessons we must learn from the COVID-19 pandemic?

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

Exploring the potential of vaccines for treatment equity.

Your roundup of the key scientific studies and industry announcements emerging from the pandemic.

Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing